Participation in IPO
(initial public offering)

Unique investment before the start of trading
Participate in IPO
YXR YX Asset Recovery Ltd 20.11.2019 Participate in IPO
SITM SiTime Corp 21.11.2019 Participate in IPO
CAN Canaan Inc 21.11.2019 Participate in IPO
LMPX LMP Automotive Holdings 22.11.2019 Participate in IPO
YZCM Leaping Group Co., Ltd. 22.11.2019 Participate in IPO
Contact usCollapse

How to invest in IPO

Find IPO
Our calendar contains the latest and most relevant information on initial public offerings.
Open MT5 Global account
Thousands of instruments for investing and trading.
Transfer funds to a trading account
Instant deposit and withdrawal in many convenient ways.
Apply for IPO in the Private Office or MT5 Global trading platform
Preliminary position will immediately appear in the portfolio.

IPO Calendar

YXR
YX Asset Recovery Ltd
IPO
Date
20.11.2019
Price range, $
$7.75 - $9.75

We are a leading business service provider of delinquent consumer debt collection in China.

SITM
SiTime Corp
IPO
Date
21.11.2019
Price range, $
$13 - $15

We are a leading provider of silicon timing systems solutions. Our timing solutions are the heartbeat of our customers’ electronic systems, solving complex timing problems and enabling industry-leading products.

CAN
Canaan Inc
IPO
Date
21.11.2019
Price range, $
$9 - $11

We provide supercomputing solutions through our proprietary high performance computing ASICs.

LMPX
LMP Automotive Holdings
IPO
Date
22.11.2019
Price range, $
$5 - $6

LMP, through its wholly owned subsidiaries, currently offers our customers the opportunity to buy, sell, rent and subscribe for, and obtain financing for automobiles both online and in person.

YZCM
Leaping Group Co., Ltd.
IPO
Date
22.11.2019
Price range, $
$4 - $6

Multimedia service provider based in Shenyang, China, with business relationships with national advertising clients.

CPZ
Calamos Long/Short Equity & Dynamic Income Trust
IPO
Date
26.11.2019
Price range, $
$20 - $20

A newly organized, diversified, closed-end management registered investment company with at least 80% of managed assets invested in equity securities and up to 20% in globally diversified income-producing securities. (see prospectus & brochure for complete strategy overview)

FBIOP
Fortress Biotech, Inc.
Follow-on
Date
26.11.2019
Price range, $
Expected

FOLLOW-ON OFFERING: Preferred stock. Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing pharmaceutical and biotechnology products and product candidates.

BIVI
BIOVIE INC
Follow-on
Date
06.12.2019
Price range, $
Expected

BioVie Inc. (OTCQB: BIVI; up-listing to NASDAQ) Approximately $15,000,000 of units, with each unit consisting of one share of Class A common stock and one-half (1/2) of one warrant, each whole warrant exercisable for one share of common stock. After giving effect to the planned 1:125 reverse stock split. The final public offering price will be determined through negotiation between us and the lead underwriters in the offering and the recent market price used throughout this prospectus may not be indicative of the final offering price

NRI
Fortis Minerals
IPO
Date
Expected
Price range, $
Expected

We are a returns-focused company formed to pursue oil and natural gas mineral and royalty interest opportunities in leading oil-weighted onshore domestic resource plays.

NCTY
The9 Limited
IPO
Date
Expected
Price range, $
Expected

Our goal is to become a diversified high-tech Internet company targeting fast growing technology sectors primarily in China. Our business segments primarily consist of online games and electric vehicles through our joint venture agreement with Faraday&Future Inc. or F&F.

HZ
HeZhong International (Holding) Ltd
IPO
Date
Expected
Price range, $
$4 - $4

We are a rapidly-growing online peer-to-peer lending marketplace facilitating loans between borrowers and investors, providing borrowers accessible, affordable credit and offering investors attractive risk-adjusted returns. From our inception through June 30, 2018, we have matched loan transactions with an aggregate value of approximately RMB4.99 billion ($743.53 million). We primarily conduct our businesses in Guangdong Province, China and service exclusively Chinese borrowers and investors.

INBX
Inhibrx
IPO
Date
Expected
Price range, $
Expected

We are a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.

ANVS
Annovis Bio
IPO
Date
Expected
Price range, $
$6 - $8

Annovis is a clinical stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease in Down syndrome (AD-DS), Alzheimer's disease (AD) and Parkinson's disease (PD).

KRAT
Karat Packaging
IPO
Date
Expected
Price range, $
$7 - $9

We are a rapidly-growing manufacturer and distributor of environmentally-friendly, single-use disposable products primarily used in restaurants and foodservice settings. We supply a wide range of products for the foodservice industry, including food packaging, containers, tableware, cups, lids, cutlery and straws.

CNTX
Centrexion Therapeutics Corp
IPO
Date
Expected
Price range, $
Expected

We are a late clinical-stage biopharmaceutical company focused on becoming the leader in identifying, developing and commercializing novel, non-opioid and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain.

BRP
BRP Group
IPO
Date
Expected
Price range, $
Expected

Independent insurance distribution firm.

PGNY
Progyny, Inc
IPO
Date
Expected
Price range, $
Expected

Progyny is a leading benefits management company specializing in fertility and family building benefits solutions in the United States.

DDDD
4D Molecular Therapeutics
IPO
Date
Expected
Price range, $
Expected

We are a development stage precision gene therapy company dedicated to pioneering the development of targeted therapies based on our next-generation AAV vectors.

PHAT
Phathom Pharmaceuticals
IPO
Date
Expected
Price range, $
Expected

We are a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases.

CABA
Cabaletta Bio
IPO
Date
Expected
Price range, $
Expected

We are a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases.

DAO
Youdao
IPO
Date
Expected
Price range, $
Expected

Youdao has developed and used technologies to provide learning content, applications and solutions to users of all ages

BEAM
Beam Therapeutics
IPO
Date
Expected
Price range, $
Expected

We are a biotechnology company committed to creating a new class of precision genetic medicines based on our proprietary base editing technology, with a vision of providing life-long cures to patients suffering from serious diseases.

TFFP
TFF Pharmaceuticals
IPO
Date
Expected
Price range, $
$5 - $5

We are an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on our patented Thin Film Freezing, or TFF, technology platform.

OYST
Oyster Point Pharma
IPO
Date
Expected
Price range, $
Expected

We are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases.

CMDS
CloudMinds
IPO
Date
Expected
Price range, $
Expected

We have built and operate an open end-to-end cloud robot system, and offer it as a service to the world.

REPX
Riley Exploration - Permian
IPO
Date
Expected
Price range, $
Expected

We are a growth-oriented, independent oil and natural gas company focused on rapidly growing our reserves, production and cash flow through the acquisition, exploration, development and production of oil, natural gas, and natural gas liquids, or NGLs, reserves in the Permian Basin.

OLB
OLB GROUP
IPO
Date
Expected
Price range, $
Expected

UPLISTING: We are FinTech company and payment facilitator (“PayFac”) that focuses on a suite of products in the merchant services and payment facilitator verticals and provides integrated business solutions to merchants throughout the United States.

AIH
Aesthetic Medical International Holdings Group
IPO
Date
Expected
Price range, $
Expected

Aesthetic medical service company.

HUIZ
Huize Holding Ltd
IPO
Date
Expected
Price range, $
Expected

We are a leading independent online insurance product and service platform in China that is not affiliated with insurance companies or other insurance industry participants.

RAPT
RAPT Therapeutics
IPO
Date
Expected
Price range, $
Expected

We are a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.

VRME
VerifyMe, Inc.
Follow-on
Date
Expected
Price range, $
Expected

FOLLOW-ON OFFERING: Nasdaq uplisting; VerifyMe, Inc. (“VerifyMe,” the “Company,” “we” or “us”) is a developmental stage technology solutions provider specializing in brand protection functions such as counterfeit prevention, authentication, serialization, track and trace features for labels, packaging and products.

DNK
Phoenix Tree Holdings Ltd
IPO
Date
Expected
Price range, $
Expected

We started Danke in 2015 to provide young people with comfortable yet affordable homes. Today, we are one of the largest co-living platforms in China with the fastest growth, according to iResearch.

IMAB
I-Mab
IPO
Date
Expected
Price range, $
Expected

We are a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.

LIZI
LIZHI Inc
IPO
Date
Expected
Price range, $
Expected

Audio technology company.

VEL
Velocity Financial
IPO
Date
Expected
Price range, $
Expected

We are a vertically integrated real estate finance company founded in 2004. We primarily originate and manage investor loans secured by 1-4 unit residential rental and small commercial properties, which we refer to collectively as investor real estate loans.

ANPC
AnPac Bio-Medical Science
IPO
Date
Expected
Price range, $
Expected

We are a biotechnology company focusing on early cancer screening and detection. We market and sell a multi-cancer screening and detection test that uses our innovative, patented cancer differentiation analysis, or CDA, technology and our proprietary cancer-detection device, or CDA device.

EH
EHang Holdings
IPO
Date
Expected
Price range, $
Expected

We are an autonomous aerial vehicle technology platform company. We are pioneering the future of transportation through our proprietarily developed autonomous aerial vehicles, or AAVs, and related commercial solutions.

ML
Meili Auto Holdings
IPO
Date
Expected
Price range, $
Expected

We are a pioneer and leader in China’s used car financing market, focusing on facilitating loans from financial institutions to prime borrowers in used car transactions.

SPT
Sprout Social
IPO
Date
Expected
Price range, $
Expected

Introduced in 2011, our cloud software brings together social messaging, data and workflows in a unified system of record, intelligence and action.

FUV
Arcimoto Inc
Follow-on
Date
19.11.2019
Price range, $
Expected

Engaged primarily in the design and development of ultra-efficient three-wheeled electric vehicles.

CNSP
CNS Pharmaceuticals
IPO
Date
08.11.2019
Price range, $
$4 - $5

We are a preclinical stage pharmaceutical company organized as a Nevada corporation in July 2017 to focus on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors.

MOHO
ECMOHO Ltd
IPO
Date
08.11.2019
Price range, $
$10 - $12

We are one of China’s leading integrated solution providers in the rapidly growing non-medical health and wellness market. As an integrated solution provider, we act as the bridge between brand owners and Chinese consumers by marketing and distributing health supplements and food, mother and child care products, personal care products, household healthcare equipment and other health and wellness products.

TELA
TELA Bio
IPO
Date
08.11.2019
Price range, $
$14 - $16

We are a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.

SI
Silvergate Capital Corp
IPO
Date
08.11.2019
Price range, $
$13 - $15

Silvergate Capital Corporation is the holding company for our wholly-owned subsidiary, Silvergate Bank, which we believe is the leading provider of innovative financial infrastructure solutions and services to participants in the nascent and expanding digital currency industry.

MNPR
Monopar Therapeutics
IPO
Date
08.11.2019
Price range, $
$8 - $10

We are a clinical stage biopharmaceutical company focused on developing proprietary therapeutics designed to improve clinical outcomes for cancer patients.

HYLT
Hylete, Inc
IPO
Date
07.11.2019
Price range, $
$8 - $10

We are a digitally native, fitness lifestyle company engaged in the design, development, manufacturing and distribution of premium performance apparel, footwear, and gear for men and women, including shorts, pants, tops, jeans, tights, crops, dresses, t-shirts, tanks, thermals, henleys, polos, base layer, jackets, hoodies, hats, underwear, socks, footwear, bags, backpacks, and other accessories.

GFL
GFL Environmental Inc.
IPO
Date
07.11.2019
Price range, $
$20 - $24

Subordinate Voting Shares: GFL is the fourth largest diversified environmental services company in North America, as measured by revenue and North American operating footprint.

GRTX
Galera Therapeutics
IPO
Date
07.11.2019
Price range, $
$14 - $16

We are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.

CNTG
Centogene B.V.
IPO
Date
07.11.2019
Price range, $
$14 - $16

We are a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies.